TIAA: SPR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TIAA on SPR, newest first. How the timeline and the estimate are built.
TIAA held 0 SPR shares at 2025-12-31 per its 13F-HR filed 2026-02-12.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -498,977 shares
13F-HR 0000930413-26-000405 filed by Nuveen, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 498,977 sharesChange vs previous 13F +157,299 shares
0.01% of the 13F portfolio, value $19,260,512.
13F-HR 0000930413-25-003416 filed by Nuveen, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 341,678 sharesChange vs previous 13F +87,054 shares
<0.01% of the 13F portfolio, value $13,035,015.
13F-HR 0000930413-25-002413 filed by Nuveen, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 254,624 sharesChange vs previous 13F -26,055 shares
<0.01% of the 13F portfolio, value $8,774,343.
13F-HR 0000930413-25-001717 filed by Nuveen, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 280,679 sharesChange vs previous 13F -25,067 shares
<0.01% of the 13F portfolio, value $9,565,540.
13F-HR 0000930413-25-000580 filed by Nuveen Asset Management, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 305,746 sharesChange vs previous 13F not available
<0.01% of the 13F portfolio, value $9,939,802.
13F-HR 0000930413-24-003166 filed by Nuveen Asset Management, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).